FDA.reportPublic FDA data

Matzim LA 360 MG 24 HR Extended Release Oral Tablet

RxCUI
1091638
RxNorm name
Matzim LA 360 MG 24 HR Extended Release Oral Tablet
Display name
Matzim LA 360 MG 24 HR Extended Release Oral Tablet
Full name
Matzim LA 360 MG 24 HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e8c8dd18-9d95-4068-9762-bec1eb1bc25cMatzim LA 360 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR diltiazem hydrochloride 360 MG Extended Release Oral Tablet [Matzim] [SBD] · 24 HR Matzim 360 MG Extended Release Oral Tablet [SY] · Matzim LA 360 MG 24 HR Extended Release Oral Tablet [SY]413These highlights do not include all the information needed to use MATZIM LA (DILTIAZEM HYDROCHLORIDE) EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MATZIM LA (DILTIAZEM HYDROCHLORIDE) EXTENDED-RELEASE TABLETS. Matzim ® LA (DILTIAZEM HYDROCHLORIDE) extended-release tablets, for oral use Initial U.S. Approval: 198220250501